U.S. News & World Report ranks our cancer program #1 in the Philadelphia region and 7th in the nation for cancer care.
The CAR-T therapy developed at Penn may be a promising treatment option following Sen. John McCain’s recent glioblastoma diagnosis.
The New York Times discusses the gene-altering treatment developed at Penn.
We are ranked #1 in the Philadelphia region and 7th in the nation for cancer care by U.S. News & World Report.
Clinical trials help cancer survivors live longer and have a better quality of life through new ways to detect, diagnose and treat cancer.
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.